Xtx Topco LTD Deciphera Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.58 - $17.36 $394,037 - $503,717	29,016 New	29,016 $456,000
Q3 2023 Nov 13, 2023	BUY	$12.46 - $15.48 $319,324 - $396,721	25,628 New	25,628 $325,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $281,459 - $459,929	22,735 New	22,735 $421,000
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $167,648 - $271,117	-24,403 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $187,903 - $906,083	24,403 New	24,403 $238,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.